Medicare Enrolled
Dr. David Ragan, M.D.
Urology Physician · North Chicago, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ragan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ragan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ragan
Dr. David Ragan is an urology physician in North Chicago, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ragan performed 15,289 Medicare services across 1,935 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ragan received a total of $10,226 from 52 pharmaceutical and/or device companies across 463 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ragan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in IL
$10,226 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,289
Medicare services
Top 6% in IL for urology physician
1,935
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~764 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, degarelix, 1 mg | 4,240 | $3 | $6 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,350 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 2,760 | $19 | $29 |
| BCG treatment for bladder cancer | 1,251 | $2 | $6 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 635 | $133 | $351 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
593 | $8 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
366 | $69 | $231 |
| PSA test (prostate cancer screening) | 347 | $18 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
342 | $96 | $335 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
292 | $2 | $14 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
209 | $25 | $86 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
203 | $27 | $99 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
143 | $131 | $450 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
124 | $50 | $191 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
85 | $9 | $32 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
43 | $64 | $320 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $64 | $222 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
33 | $39 | $145 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $12 | $44 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
29 | $73 | $275 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
27 | $5 | $17 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
23 | $18 | $61 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
22 | $5 | $27 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
21 | $20 | $69 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
18 | $64 | $244 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $101 | $621 |
| Abdominal X-ray, 2 views An X-ray imaging test of the abdomen using two different angles to visualize internal structures. |
16 | $19 | $112 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
13 | $54 | $612 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
12 | $198 | $1,022 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $98 | $510 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2023 ↗$10,226
Total received (2018-2023)
Avg $1,704/year across 6 years
Top 17% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
463
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,770 (85.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,455 (14.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$2,184
2022
$2,521
2021
$1,401
2020
$746
2019
$1,337
2018
$2,037
Payments by company (2023)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$342
ABBVIE INC.
$295
Bayer Healthcare Pharmaceuticals Inc.
$234
PFIZER INC.
$192
Sumitomo Pharma America, Inc.
$192
Astellas Pharma US Inc
$161
Merck Sharp & Dohme LLC
$137
Progenics Pharmaceuticals, Inc.
$114
AstraZeneca Pharmaceuticals LP
$91
ACCORD HEALTHCARE, INC.
$48
C. R. Bard, Inc. & Subsidiaries
$47
Amgen Inc.
$46
Myriad Genetic Laboratories, Inc.
$42
UroGen Pharma, Inc.
$37
Verity Pharmaceuticals Inc.
$35
Dendreon Pharmaceuticals LLC
$34
Supernus Pharmaceuticals, Inc.
$25
Sun Pharmaceutical Industries Inc.
$24
Blue Earth Diagnostics Limited
$21
Novo Nordisk Inc
$20
Novartis Pharmaceuticals Corporation
$19
Foundation Medicine, Inc.
$16
Endo Pharmaceuticals Inc.
$15
Top 3 companies account for 39.9% of 2023 payments
All-time payments by company (2018-2023) ›
Astellas Pharma US Inc
$1,752
PFIZER INC.
$1,700
Janssen Biotech, Inc.
$1,100
Bayer HealthCare Pharmaceuticals Inc.
$650
ABBVIE INC.
$490
Dendreon Pharmaceuticals LLC
$329
Amgen Inc.
$321
Blue Earth Diagnostics Limited
$315
Endo Pharmaceuticals Inc.
$287
Bayer Healthcare Pharmaceuticals Inc.
$234
Allergan, Inc.
$234
Sumitomo Pharma America, Inc.
$192
Progenics Pharmaceuticals, Inc.
$191
Allergan Inc.
$179
AbbVie, Inc.
$165
Merck Sharp & Dohme LLC
$155
Clarus Therapeutics Inc.
$143
AstraZeneca Pharmaceuticals LP
$120
AbbVie Inc.
$120
Aytu BioScience, Inc
$116
Avadel Specialty Pharmaceuticals, LLC
$103
Janssen Products, LP
$100
Myriad Genetic Laboratories, Inc.
$93
Ferring Pharmaceuticals Inc.
$91
UROVANT SCIENCES INC
$78
TOLMAR Pharmaceuticals, Inc.
$74
C. R. Bard, Inc. & Subsidiaries
$74
Myovant Sciences Inc.
$73
UroGen Pharma, Inc.
$55
Verity Pharmaceuticals Inc.
$54
Foundation Medicine, Inc.
$51
ACCORD HEALTHCARE, INC.
$48
Travere Therapeutics, Inc.
$44
BOSTON SCIENTIFIC CORPORATION
$43
Antares Pharma, Inc.
$39
Novartis Pharmaceuticals Corporation
$37
Acerus Pharmaceuticals Corporation
$32
Retrophin, Inc.
$30
UROGEN PHARMA, INC.
$30
ABC Home Medical Supply, Inc.
$29
MEDIVATION FIELD SOLUTIONS LLC
$29
Alnylam Pharmaceuticals Inc.
$25
Supernus Pharmaceuticals, Inc.
$25
Coloplast Corp
$24
Sun Pharmaceutical Industries Inc.
$24
Accord Healthcare, Inc.
$24
Rochester Medical Corporation
$22
COLOPLAST CORP
$21
Novo Nordisk Inc
$20
Boston Scientific Corporation
$18
Janssen Scientific Affairs, LLC
$14
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 44.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AVYCAZ · Androgel · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CAMCEVI · Dormia · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL THERAPIES · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OXLUMO · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · SUTENT · TALZENNA · TITAN · TOVIAZ · Thiola · Trelstar · VESICARE · VIAGRA · Wegovy · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
100
Per 100K population
14.0
County median income
$108,917
Nearest hospital
NORTH CHICAGO VA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ragan is a mixed practice specialist, with above-average Medicare volume (top 6% in IL), with low-engagement industry engagement in the top 17% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ragan experienced with injection, degarelix, 1 mg?
Based on Medicare claims data, Dr. Ragan performed 4,240 injection, degarelix, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ragan receive payments from pharmaceutical companies?
Yes. Dr. Ragan received a total of $10,226 from 52 companies across 463 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ragan's costs compare to other urology physicians in North Chicago?
Dr. Ragan's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ragan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in North Chicago
Browse urology physicians in North Chicago ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology